Andrew H Wei

Andrew H Wei

UNVERIFIED PROFILE

Are you Andrew H Wei?   Register this Author

Register author
Andrew H Wei

Andrew H Wei

Publications by authors named "Andrew H Wei"

Are you Andrew H Wei?   Register this Author

35Publications

1163Reads

13Profile Views

New drugs creating new challenges in acute myeloid leukemia.

Genes Chromosomes Cancer 2019 Dec 11;58(12):903-914. Epub 2019 Apr 11.

Department of Haematology, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22750DOI Listing
December 2019

Polyclonal Heterogeneity: The New Norm for Secondary Clinical Resistance to Targeted Monotherapy in Relapsed Leukemia?

Cancer Discov 2019 Aug;9(8):998-1000

Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-19-0575DOI Listing
August 2019

Incorporating Precision BH3 Warheads Into the Offensive Against Acute Myeloid Leukemia.

J Clin Oncol 2019 Jul 21;37(21):1785-1789. Epub 2019 May 21.

2 Alfred Hospital, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
https://ascopubs.org/doi/10.1200/JCO.19.00400
Publisher Site
http://dx.doi.org/10.1200/JCO.19.00400DOI Listing
July 2019

Maintenance therapy for AML: are we there yet?

Authors:
Andrew H Wei

Blood 2019 Mar;133(13):1390-1392

The Alfred Hospital; Monash University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2019-02-897579DOI Listing
March 2019

Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome.

Best Pract Res Clin Haematol 2019 03 27;32(1):3-12. Epub 2019 Feb 27.

The Alfred Hospital and Monash University, Melbourne, VIC, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.02.007DOI Listing
March 2019

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.

Cancer Cell 2018 12;34(6):879-891

The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183052
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.11.004DOI Listing
December 2018

Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML.

Blood 2017 12 19;130(23):2469-2474. Epub 2017 Oct 19.

Department of Clinical Haematology, Alfred Hospital, Melbourne, Australia; and.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2017-08
Publisher Site
http://dx.doi.org/10.1182/blood-2017-08-784066DOI Listing
December 2017

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

J Clin Oncol 2017 May 3;35(15):1678-1685. Epub 2017 Apr 3.

Kenneth F. Bradstock and Warwick Benson, Westmead Hospital, University of Sydney; Arno Enno, Sandra Deveridge, and Philip Rowlings, Calvary Mater Newcastle Hospital, Newcastle; Luke Coyle, Royal North Shore Hospital, St Leonards; Campbell Tiley, Central Coast Health, Gosford; John Moore, St Vincent's Hospital; Mark Hertzberg, Prince of Wales Hospital, Sydney; Kimberly Cartwright, Wollongong Hospital, Wollongong; Ilona Cunningham, Concord Repatriation General Hospital, Concord; John Taper, Nepean Hospital, Penrith, New South Wales; Emma Link, Juliana Di Iulio, and John F. Seymour, Peter MacCallum Cancer Centre; Jeff Szer, Andrew Grigg, Andrew W. Roberts, and John F. Seymour, University of Melbourne; Andrew H. Wei, Monash University; Anthony Schwarer, Box Hill Hospital; Lynda Campbell, Victorian Cancer Cytogenetics Service, Melbourne; Jeff Szer, Andrew Grigg, and Andrew W. Roberts, Royal Melbourne Hospital, Parkville; Phillip Campbell, Deakin University School of Medicine, Geelong, Victoria; Paula Marlton, Anthony K. Mills, and Devinder Gill, University of Queensland, Brisbane, Queensland; Ray M. Lowenthal, University of Tasmania, Hobart, Tasmania; Ian D. Lewis and Peter Bardy, Royal Adelaide Hospital; Uwe Hahn, Queen Elizabeth Hospital, Adelaide, South Australia; James D'Rozario, The Canberra Hospital, Garran, Canberra, Australia Capital Territory; Gavin Cull, Sir Charles Gairdner Hospital; Michael F. Leahy, University of Western Australia; and Paul Cannell, Royal Perth Hospital, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.6374
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.6374DOI Listing
May 2017

Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia.

Br J Haematol 2017 04 31;177(2):328-330. Epub 2016 Mar 31.

Department of Haematology, Alfred Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14063DOI Listing
April 2017

'Did He Who Made the Lamb Make Thee?' New Developments in Treating the 'Fearful Symmetry' of Acute Myeloid Leukemia.

Trends Mol Med 2017 03 11;23(3):264-281. Epub 2017 Feb 11.

The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; Department of Medical Biology, University of Melbourne, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2017.01.005DOI Listing
March 2017

Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9.

Bioorg Med Chem 2015 Oct 28;23(19):6280-96. Epub 2015 Aug 28.

ACRF Chemical Biology Division, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, 1G Royal Parade, VIC 3052, Australia; School of Chemistry, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, 30 Flemington Rd, VIC 3010, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2015.08.035DOI Listing
October 2015

Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.

Blood 2015 Apr 3;125(18):2815-24. Epub 2015 Mar 3.

Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia; Department of Clinical Haematology, The Alfred Hospital, Melbourne, VIC, Australia;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-09-603555DOI Listing
April 2015

The epigenomics revolution in myelodysplasia: a clinico-pathological perspective.

Pathology 2011 Oct;43(6):536-46

Department of Clinical Haematology, The Alfred Hospital, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0b013e32834a4061DOI Listing
October 2011

Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1.

PLoS Pathog 2010 Dec 23;6(12):e1001236. Epub 2010 Dec 23.

The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.ppat.1001236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009601PMC
December 2010

New insights into the haemostatic function of platelets.

Br J Haematol 2009 Nov 28;147(4):415-30. Epub 2009 Jul 28.

The Australian Centre for Blood Diseases, Monash University, Department of Haematology, Alfred Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2009.07819.xDOI Listing
November 2009

In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas.

Proc Natl Acad Sci U S A 2008 Nov 11;105(46):17961-6. Epub 2008 Nov 11.

The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0809957105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582212PMC
November 2008

Bortezomib: putting mantle cell lymphoma on death row.

Leuk Lymphoma 2008 Apr;49(4):657-8

Department of Malignant Haematology and Stem Cell Transplantion, The Alfred Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190801942378DOI Listing
April 2008